Jeena Sikho Lifecare: పశ్చిమ బెంగాల్లో కొత్త ఆయుర్వేద హాస్పిటల్.. ఇన్వెస్టర్లకు శుభవార్త!
NiveshIQ
NSE: JSLL · Consumer Services
Jeena Sikho Lifecare Ltd.
₹564.90▲ ₹0.45 (+0.08%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on JSLL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Jeena Sikho Lifecare Ltd.
Jeena Sikho Lifecare Limited (JSLL) is a leading player in the Indian healthcare sector, primarily focused on trading in ayurvedic medicines under the Shuddhi brand name. The company offers a range of services, including in-patient and out-patient facilities, health camps, Panchakarma therapies, and home-based healthcare services. JSLL operates multiple clinics across India, providing comprehensive healthcare solutions to its customers. The company's revenue has grown significantly, reaching ₹725 Cr, with a net income of ₹213 Cr. Recent developments, including a 100% surge in stock price, have garnered attention from investors and analysts. JSLL's competitive position is strengthened by its strong brand presence and diversified service offerings. With a growth outlook driven by increasing
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹324.00 Cr +58.80% | ₹469.00 Cr +44.80% | ₹801.36 Cr +70.90% |
| EBITDA Margin | 28.70% | 26.65% | 44.66% |
| Net Profit | ₹69.00 Cr +102.90% | ₹91.00 Cr +31.90% | ₹221.70 Cr +143.60% |
| EPS | ₹5.57 | ₹7.30 | ₹17.84 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Jeena Sikho Lifecare: ਪੱਛਮੀ ਬੰਗਾਲ ਵਿੱਚ ਖੁੱਲ੍ਹੇਗਾ 60 ਬੈੱਡਾਂ ਵਾਲਾ ਨਵਾਂ ਹਸਪਤਾਲ
Jeena Sikho Lifecare Appoints New Company Secretary, Expands Board
🔒
+ 3 more stories about Jeena Sikho Lifecare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹216 Cr, PAT ₹45 Cr, EPS ₹3.65, EBITDA margin 37.8%. Growth context: revenue QoQ -2.9%, PAT QoQ -32.3%. Street verdict: miss, revenue surprise -3.5%, PAT surprise -11.5%.
Patient volumes, occupancy, ARPOB/ARPO, case mix, and bed-capacity ramp-up remain the key forward drivers for the next 2...
FY26 (last completed FY): revenue ₹801 Cr, PAT ₹222 Cr, EBITDA margin 44.7%, EPS ₹17.87. Year-on-year: revenue YoY +70.9...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for JSLL
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track JSLL alongside your other holdings
Unlock full JSLL research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Jeena Sikho Lifecare Ltd.?
NiveshIQ detects active intelligence signals for Jeena Sikho Lifecare Ltd. (JSLL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Jeena Sikho Lifecare Ltd.?
Jeena Sikho Lifecare Ltd. operates in the Consumer Services sector with a market capitalisation of ₹611,559.6L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.